Advertisement
Home 2016

Yearly Archives: 2016

For patients with HIV-associated cryptococcal meningitis

Dexamethasone No Help in HIV-Linked Cryptococcal Meningitis

0
Dexamethasone doesn't reduce mortality; linked to higher percentage of patients with disability
Only one-in-five patients with heart failure with reduced ejection fraction receive digoxin at discharge

Use of Digoxin Down Among Patients With Heart Failure

0
Only one-in-five with heart failure with reduced ejection fraction receive digoxin at discharge
Discharging patients on the same day following a minimally invasive myomectomy appears to be a safe option

Same-Day Discharge OK for Minimally Invasive Myomectomy

0
Low readmission rate within 48 hours and no life-threatening events or reoperation
Functional magnetic resonance imaging with central sensitization can be used in early human drug development

Functional Imaging Beneficial for Analgesic Drug Development

0
Functional magnetic resonance imaging with central sensitization beneficial for selecting analgesics
For patients with alcohol withdrawal syndrome

Sedatives Appear to Be Safe in Alcohol Withdrawal Syndrome

0
High-dose intravenous sedatives not associated with excess morbidity or mortality
For patients with actinic keratoses

Artificial White Light Effective for Actinic Keratoses

0
White light as effective and well tolerated as daylight for photodynamic therapy
The rate of missed adenomas larger than 5 mm is similarly low for men with Boston Bowel Prep Scale scores of 2 or 3

Rate of Missed Adenomas >5 mm Similarly Low for BBPS 2, 3

0
Significantly higher rate of missed adenomas in colon segments with Boston Bowel Prep Scale score of 1
The rate of smoking during pregnancy is about 8.4 percent

CDC: Rate of Smoking 8.4 Percent at Any Time During Pregnancy

0
Highest prevalence for women 20 to 24 years and for non-Hispanic American Indian, Alaska Natives
Among young women with breast cancer

Rates of BRCA Mutation Testing Increasing in Young Women

0
Among young women diagnosed with breast cancer, frequency of testing >95 percent in 2013
Caplacizumab

Caplacizumab Shows Potential for Treating Acquired TTP

0
In a phase 2 study, the biopharmaceutical induced faster resolution of acute TTP episode than placebo